×
Motif Bio Plc Price to Free Cash Flow Ratio 2015-2020 | MTFB
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Motif Bio Plc price to free cash flow ratio from 2015 to 2020. Price to free cash flow ratio can be defined as
View More
Motif Bio Plc Price to Free Cash Flow Ratio 2015-2020 | MTFB
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Motif Bio Plc price to free cash flow ratio from 2015 to 2020. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Amgen (AMGN)
$173B
Vertex Pharmaceuticals (VRTX)
$129.4B
Gilead Sciences (GILD)
$121.9B
Bristol Myers Squibb (BMY)
$111B
CSL (CSLLY)
$91.9B
Regeneron Pharmaceuticals (REGN)
$90.6B
GSK (GSK)
$76B
Argenex SE (ARGX)
$35.4B
Alnylam Pharmaceuticals (ALNY)
$35.1B
BioNTech SE (BNTX)
$25.7B
Biogen (BIIB)
$25.3B
Illumina (ILMN)
$24.6B
BeiGene (BGNE)
$20.1B
Moderna (MRNA)
$19.3B
Incyte (INCY)
$15.9B
Genmab (GMAB)
$15.3B
Insmed (INSM)
$12.8B
Vaxcyte (PCVX)
$12.8B
BioMarin Pharmaceutical (BMRN)
$12.8B
Bio-Techne Corp (TECH)
$12.1B
Sarepta Therapeutics (SRPT)
$11.5B
Exelixis (EXEL)
$10.2B
QIAGEN (QGEN)
$10.1B
Revolution Medicines (RVMD)
$9.9B
Exact Sciences (EXAS)
$9.9B
Intra-Cellular Therapies (ITCI)
$9.6B
Bio-Rad Laboratories (BIO.B)
$9.4B
Roivant Sciences (ROIV)
$8.7B
Repligen (RGEN)
$8.1B
Ascendis Pharma (ASND)
$7.7B